Immune and inflammatory mechanisms and therapeutic targets of gout: An update
International Immunopharmacology · 2023-08 · 121 · 110466
DOI: 10.1016/j.intimp.2023.110466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-08. Verfasst von Wenji Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, 330006 Nanchang, China; The Second Clinical Medical …. Hauptthemen laut MEDLINE: Gout, Arthritis, Gouty. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 200 Literaturangaben. Gefördert von: Nanchang University, Jiangsu Provincial Commission of Health and Family Planning.
Abstract (Originalsprache)
Gout is an autoimmune disease characterized by acute or chronic inflammation and damage to bone joints induced due to the precipitation of monosodium urate (MSU) crystals. In recent years, with the continuous development of animal models and ongoing clinical investigations, more immune cells and inflammatory factors have been found to play roles in gouty inflammation. The inflammatory network involved in gout has been discovered, providing a new perspective from which to develop targeted therapy for gouty inflammation. Studies have shown that neutrophil macrophages and T lymphocytes play important roles in the pathogenesis and resolution of gout, and some inflammatory cytokines, such as those in the interleukin-1 (IL-1) family, have been shown to play anti-inflammatory or proinflammatory roles in gouty inflammation, but the mechanisms underlying their roles are unclear. In this review, we explore the roles of inflammatory cytokines, inflammasomes and immune cells in the course of gout development and the research status of therapeutic drugs used for inflammation to provide insights into future targeted therapy for gouty inflammation and the direction of gout pathogenesis research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, 330006 Nanchang, China; The Second Clinical Medical College of Nanchang University, 330006 Nanchang, China.
- Queen Mary College of Nanchang University, 330006 Nanchang, China.
- Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, 1 MinDe Road, 330006 Nanchang, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, 330006 Nanchang, China. Electronic address: tcmclinic@163.com.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Nanchang University, 330006 Nanchang, China. Electronic address: ndyfy04408@ncu.edu.cn.
Förderung
- Nanchang University
- Jiangsu Provincial Commission of Health and Family Planning
Zitieren
APA
Liu, W., Peng, J., Wu, Y., Ye, Z., Zong, Z., Wu, R., & Li, H. (2023). Immune and inflammatory mechanisms and therapeutic targets of gout: An update. International Immunopharmacology, 121, 110466. https://doi.org/10.1016/j.intimp.2023.110466
Vancouver
Liu W, Peng J, Wu Y, Ye Z, Zong Z, Wu R, et al. Immune and inflammatory mechanisms and therapeutic targets of gout: An update. International Immunopharmacology. 2023;121:110466. doi:10.1016/j.intimp.2023.110466
BibTeX
@article{Liu2023,
author = {Liu, Wenji and Peng, Jie and Wu, Yixin and Ye, Zuxiang and Zong, Zhen and Wu, Rui and Li, Hui},
title = {Immune and inflammatory mechanisms and therapeutic targets of gout: An update},
journal = {International Immunopharmacology},
year = {2023},
volume = {121},
pages = {110466},
doi = {10.1016/j.intimp.2023.110466}
}
EUVIMED